27/02/2019
Alternating P Wave Morphology | Circulation
HomeCirculationVol. 139, No. 9Alternating P Wave Morphology Free AccessarticleDownload PDFAboutView Full TextView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyGoogle+ ShareRedditDiggEmail Jump toFree AccessarticleDownload....
15/02/2019
जीवन रेखा अस्पताल जगतपुरा जयपुर लेकर आए हैं,
विशाल ह्रदय रोग निवारण शिविर
13 से 20 फरवरी तक,
जीवन रेखा हॉस्पिटल में, एंजियोग्राफी पर 50% एवं एंजियोप्लास्टी पर 20% छूट ।
हैप्पी हार्ट पैकेज मात्र ₹ 999 , संपर्क करे- 8003399993
रखें आपके जीवन का ख्याल , दिल से।
25/11/2018
PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study
While noninferior to placebo for the primary MACE endpoint, the GLP-1 agonist was linked with a mortality benefit in patients with type 2 diabetes.
13/11/2018
Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages
The amount of exercise mandated weekly hasn’t changed, but gone are the 10-minute blocks that marked bouts of physical activity.
21/09/2018
Dr. Anupam Jena, Interventional Cardiologist and Electrophysiologist on Google
LARGE PSEUDOANEURYSM OF CAROTID ARTERY TREATED WITH COVERED STENTING A 50 years old male patient presented with swelling in the neck, difficulty in swallowing and hoarseness of voice. Initially the swelling was thought to be tumor and investigated. CT scan showed the mass to be a large pseudoaneurys...
26/06/2018
CVD Prevention and Control Remains a Challenge in India
A new report maintains that investing in healthcare, taking a harder line on prevention, and encouraging yoga are important steps to improving care.
04/06/2018
Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval
The agent is the second antidote approved for the NOACs, joining idarucizumab, dabigatran’s reversal agent.
28/12/2017
Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond
TCTMD journalists asked a range of experts about what developments rocked the field this year—or at least made it tremble. Here’s what they had to say.
14/12/2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation — NEJM
Original Article from The New England Journal of Medicine — Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
14/12/2017
SGLT1/2 Inhibition for Type 1 Diabetes — NEJM
Quick Take Video Summary from The New England Journal of Medicine — SGLT1/2 Inhibition for Type 1 Diabetes
14/12/2017
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis — NEJM
Original Article from The New England Journal of Medicine — Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis